PDCI Welcomes Véronique Scott & Ishan Kumar to the Team
Ishan Kumar joins PDCI
as Manager, Data Innovation and Insights. As a member of PDCI’s data insights
team, Ishan’s role includes designing ... Read More
John Anacleto Joins PDCI as Director of Private Payer Strategies & Data Insights
Please join us in welcoming John to the PDCI Market Access Family!
John joins ... Read More
PMPRB: Federal Court of Appeal quashes PMPRB Alexion / Soliris Decision with Significant Implications for the New PMPRB Guidelines
In a unanimous July 29 decision, the Federal Court of Appeal (FCA) overturned a Federal Court judicial review and quashed the PMPRB decision in ... Read More
Deadline Extended: PMPRB Notice and Comment - New Price Tests for Grandfathered Medicines
On July 15th, 2021, the PMPRB invited stakeholders to comment on three amendments to the regulations with responses due by August 15th 2021. PMPRB announced today that the deadline has been ... Read More
PDCI Market Access has further expanded its Market Access Team!
Jessica joins PDCI as Manager, Market Access. She will be responsible for coordinating our pricing and market access projects including HTA and payer ... Read More
This morning, June 29th, 2021, Health Canada announced an additional 6-month delay in implementation of the Patented Medicines Regulations and Final PMPRB Guidelines. The changes will now come into force on January 1, 2022. The reasons cited by Health Canada for the delay are the ongoing COVID-19 pandemic and need ... Read More
Information regarding the PMPRB guidelines and the upcoming webinar can be found here. Registration is required to attend the webinar and can be completed here.
Online Filing Tool & Transition Measures for Grandfathered and Gap MedicinesDate: Tuesday June 15th, 2021Time: 1:30-3:30pm For inquiries on ... Read More
ISPOR 2021 runs between May 17-20 with the theme of HEOR: Evolving for Tomorrow's Challenges. During the conference, PDCI Market Access will be presenting a poster titled: Identification of Gaps and Opportunities for Provincial Reimbursement of Oncology Companion Diagnostics in Canada on May 18th 2021 from 11:30:00 AM ... Read More
PDCI releases the latest issue of PDCI Market Access INSIGHTS, featuring research and opinion on the evolving state of private health insurance in Canada.
IN THIS ISSUE:
Commentary Private Drug Plan Management in Canada—is it really a big deal? Noel MacKay and Tari Duguay share a provocative essay on ... Read More
The PMPRB is developing a Guideline Monitoring and Evaluation Plan (GMEP) that will analyze trends in the pharmaceutical market before and after the implementation of the new framework to assess whether it is working as intended, and to inform the need for any future adjustments. The PMPRB ... Read More
